Overview

Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease

Status:
Recruiting
Trial end date:
2021-07-19
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety, feasibility, tolerability and efficacy of a new buccal film of montelukast in patients with mild to moderate Alzheimer's disease.
Phase:
Phase 2
Details
Lead Sponsor:
IntelGenx Corp.
Treatments:
Montelukast